30 C
Delhi
Monday, September 8, 2025

US FDA approves updated COVID-19 vaccines against currently circulating variants

Date:

Share post:

Donate-GC-Razorpay

Los Angeles: The US Food and Drug Administration (FDA) approved and granted emergency use authorisation for updated mRNA COVID-19 vaccines to better protect against currently circulating variants.

The FDA said on Thursday that the updated vaccines will target the Omicron variant KP.2 strain.

“Given waning immunity of the population from previous exposure to the virus and from prior vaccination, we strongly encourage those who are eligible to consider receiving an updated COVID-19 vaccine to provide better protection against currently circulating variants,” said Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research.

“The updated mRNA COVID-19 vaccines include Comirnaty and Spikevax, both of which are approved for individuals 12 years of age and older, and the Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine, both of which are authorised for emergency use for individuals 6 months through 11 years of age,” the FDA said in a press release.

Related articles

Modi, Trump, and the Mandala Chessboard: India’s Diplomatic Balancing Act

The current phase of India–U.S. relations is not one of polite smiles, ceremonial handshakes, or orchestrated trade deals....

Sikh Delegation Seeks Fresh Probe into Chittisinghpora Massacre, LG Assures Justice

A delegation of 35 Shaheed Singhs Welfare Organization, Chittisinghpora led by its Chairman, S Jagjeet Singh, called on...

When America Spoke Down to India – A Journey of Words That Wound

India and the U.S. have built a strategic bond. They share values. They have trade. They cooperate. Yet...

India Is Not Lost to China, President Trump—It Is Defining Its Own Future

U.S. President Donald J. Trump recently declared on Truth Social that America has “lost India and Russia to...